Evidence for the role of obesity in prostate cancer progression

–   Elizabeth A. Platz, Johns Hopkins Bloomberg School of Public Health

Obesity, energy balance, and colorectal cancer survivorship

–   Jeffrey Meyerhardt, Dana-Farber Cancer Institute

The impact of weight loss on cancer incidence and mortality

–   Bruce M. Wolfe, Oregon Health & Science University

Correlations of obesity, comorbidity, and treatment:
Implications for survival analysis and interpretation

–   Rachel Ballard-Barbash, NCI

10:30 am

Panel Discussion
Questions:

•  What is the current state of the evidence? What are the evidence gaps?

•  Is the evidence strong enough to recommend weight loss for individuals who are overweight or obese and who are either newly diagnosed with cancer or long-term cancer survivors?

•  Would such an approach be recommended for all survivors or a subset of individuals diagnosed with specific cancers? If the latter, which cancers are those?

•  What is the downside of recommending weight loss to cancer survivors who are overweight or obese given the high incidence of comorbidity in this population?

•  What are the methodological issues for closing the evidence gaps?

•  How do we adjust data on obesity for other factors such as physical activity and diet?

11:15 am Lunch Break

12:15 pm Session 2: Mechanisms by Which Obesity May Influence Cancer Progression
Moderator:
Stephen Hursting, University of Texas at Austin


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement